Publications en collaboration avec des chercheurs de Universidad Católica San Antonio (3)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

2021

  1. Erratum: Addendum: MCC950 closes the active conformation of NLRP3 to an inactive state (Nature chemical biology (2019) 15 6 (560-564))

    Nature chemical biology

2019

  1. MCC950 closes the active conformation of NLRP3 to an inactive state

    Nature Chemical Biology, Vol. 15, Núm. 6, pp. 560-564